APA

Singh S. K., Vobbalareddy S., Kalleda S. R., Rajjak S. A., Casturi S. R., Datla S. R., Mamidi R. N. V. S., Mullangi R., Bhamidipati R., Ramanujam R., Akella V. & Yeleswarapu K. R. (20050628). 2-hydroxymethyl-4-[5-(4-methoxyphenyl)-3-trifluoromethyl-1H-1-pyrazolyl]-1-benzenesulfonamide (DRF-4367): an orally active COX-2 inhibitor identified through pharmacophoric modulation. : Organic & biomolecular chemistry.

Chicago

Singh Sunil Kumar, Vobbalareddy Saibaba, Kalleda Srinivasa Rao, Rajjak Shaikh Abdul, Casturi Seshagiri Rao, Datla Srinivasa Raju, Mamidi Rao N V S, Mullangi Ramesh, Bhamidipati Ravikanth, Ramanujam Rajagopalan, Akella Venkateswarlu and Yeleswarapu Koteswar Rao. 20050628. 2-hydroxymethyl-4-[5-(4-methoxyphenyl)-3-trifluoromethyl-1H-1-pyrazolyl]-1-benzenesulfonamide (DRF-4367): an orally active COX-2 inhibitor identified through pharmacophoric modulation. : Organic & biomolecular chemistry.

Harvard

Singh S. K., Vobbalareddy S., Kalleda S. R., Rajjak S. A., Casturi S. R., Datla S. R., Mamidi R. N. V. S., Mullangi R., Bhamidipati R., Ramanujam R., Akella V. and Yeleswarapu K. R. (20050628). 2-hydroxymethyl-4-[5-(4-methoxyphenyl)-3-trifluoromethyl-1H-1-pyrazolyl]-1-benzenesulfonamide (DRF-4367): an orally active COX-2 inhibitor identified through pharmacophoric modulation. : Organic & biomolecular chemistry.

MLA

Singh Sunil Kumar, Vobbalareddy Saibaba, Kalleda Srinivasa Rao, Rajjak Shaikh Abdul, Casturi Seshagiri Rao, Datla Srinivasa Raju, Mamidi Rao N V S, Mullangi Ramesh, Bhamidipati Ravikanth, Ramanujam Rajagopalan, Akella Venkateswarlu and Yeleswarapu Koteswar Rao. 2-hydroxymethyl-4-[5-(4-methoxyphenyl)-3-trifluoromethyl-1H-1-pyrazolyl]-1-benzenesulfonamide (DRF-4367): an orally active COX-2 inhibitor identified through pharmacophoric modulation. : Organic & biomolecular chemistry. 20050628.